Key statistics
As of last trade, NextCure Inc (2US:DEU) traded at 1.24, 33.33% above the 52 week low of 0.93 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.25 |
---|---|
High | 1.28 |
Low | 1.21 |
Bid | 1.23 |
Offer | 1.32 |
Previous close | 1.23 |
Average volume | 1.44k |
---|---|
Shares outstanding | 27.98m |
Free float | 25.49m |
P/E (TTM) | -- |
Market cap | 40.01m USD |
EPS (TTM) | -2.20 USD |
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Announcements
- NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
- NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
- NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
- NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
- NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
- NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
- NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
- NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
- NextCure Provides Business Update and Reports Full Year 2023 Financial Results
More ▼